Conn Morgan has filed 4 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 19500 shares of Century Therapeutics, Inc. ($IPSC) on March 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Conn Morgan | Chief Finanical Officer | A | Common Stock | 19500 | $0.00 | 79,648.0000 | 78,648,958 | 32.42% | 0.02% |
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Conn Morgan | Chief Finanical Officer | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,648,958 | 9999.99% | 0.02% |
| Oct. 14, 2024 | Century Therapeutics, Inc. | $IPSC | Conn Morgan | Chief Finanical Officer | A | Common Stock | 60148 | $0.00 | 60,148.0000 | 84,704,352 | 9999.99% | 0.07% |
| Oct. 14, 2024 | Century Therapeutics, Inc. | $IPSC | Conn Morgan | Chief Finanical Officer | A | Stock Option (right to buy) | 360890 | $0.00 | 360,890.0000 | 84,704,352 | 9999.99% | 0.43% |